Reduced capacity of antibodies from patients infected with human immunodeficiency virus type 1 (HIV-1) group O to neutralize primary isolates of HIV-1 group M viruses.

Source:http://linkedlifedata.com/resource/pubmed/id/7594658

Download in:

View as

General Info

PMID
7594658